Biological and structural properties of MIP-1 alpha expressed in yeast.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Cytokine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/1043-4666(92)90040-XPMID 1617159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification and analysis of proteinase-resistant mutants of recombinant platelet-derived growth factor-BB exhibiting improved biological activity.

  1992cited by this paper
• Characterization of the structure and conformation of platelet-derived growth factor-BB (PDGF-BB) and proteinase-resistant mutants of PDGF-BB expressed in Saccharomyces cerevisiae.

  1992cited by this paper
• Biology of the RANTES/SIS cytokine family.

  1991cited by this paper
• Cloning and characterization of a gene encoding pig epidermal growth factor.

  1991cited by this paper
• Modeling the three-dimensional structure of the monocyte chemo-attractant and activating protein MCAF/MCP-1 on the basis of the solution structure of interleukin-8.

  1991cited by this paper
• Selective inhibition of primitive hemopoietic colony-forming cells by an extract from normal marrow: comparison with transforming growth factor-beta.

  1991cited by this paper
• Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells.

  1990cited by this paper
• Identification and characterization of an inhibitor of haemopoietic stem cell proliferation

  1990cited by this paper
• Macrophage inflammatory protein-1: a prostaglandin-independent endogenous pyrogen.

  1989cited by this paper
• Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF.

  1989cited by this paper
• Identification of a common signal associated with cellular proliferation stimulated by four haemopoietic growth factors in a highly enriched population of granulocyte/macrophage colony‐forming cells.

  1989cited by this paper
• The three-dimensional structure of bovine platelet factor 4 at 3.0-A resolution.

  1989cited by this paper
• Determination of the secondary structure of interleukin-8 by nuclear magnetic resonance spectroscopy.

  1989cited by this paper
• Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 on colony formation in vitro by murine and human bone marrow granulocyte/macrophage progenitor cells

  1989cited by this paper
• Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties

  1988cited by this paper
• Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors

  1988cited by this paper
• Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties [published erratum appears in J Exp Med 1989 Dec 1;170(6):2189]

  1988cited by this paper
• The conformation and stability of recombinant-derived granulocyte-macrophage colony stimulating factors.

  1988cited by this paper
• A cDNA clone used to study mRNA inducible in human tonsillar lymphocytes by a tumor promoter.

  1986cited by this paper
• Isolation of haemopoietic spleen colony forming cells.

  1986cited by this paper
• Enrichment of CFU-S proliferation inhibitor-producing cells based on their identification by the monoclonal antibody F4/80.

  1985cited by this paper
• Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

  1985cited by this paper
• Structure of a yeast pheromone gene (MF alpha): a putative alpha-factor precursor contains four tandem copies of mature alpha-factor.

  1982cited by this paper
• Structure of a yeast pheromone gene (MFα): A putative α-factor precursor contains four tandem copies of mature α-factor

  1982cited by this paper
• Estimation of globular protein secondary structure from circular dichroism.

  1981cited by this paper
• Specific inhibition of haemopoietic stem cell proliferation: characteristics of the inhibitor producing cells.

  1980cited by this paper
• Methods in yeast genetics

  1979cited by this paper
• Transformation of yeast by a replicating hybrid plasmid

  1978cited by this paper
• Regulation of CFU-S proliferation by locally produced endogenous factors.

  1977cited by this paper
• Regulation of CFU-S proliferation by locally produced endogenous factors.

  1977cited by this paper
• An Inhibitor of Stem Cell Proliferation in Normal Bone Marrow

  1976cited by this paper
• Aromatic contributions to circular dichroism spectra of proteins.

  1974cited by this paper
• MEASUREMENT OF THE KINETIC STATUS OF BONE MARROW PRECURSOR CELLS: THREE CAUTIONARY TALES

  1974cited by this paper
• Stem cell migration and proliferation during severe anemia.

  1970cited by this paper
• THE EFFECT OF DIFFERING DEMANDS FOR BLOOD CELL PRODUCTION ON DNA SYNTHESIS BY HEMOPOIETIC COLONY-FORMING CELLS OF MICE.

  1965cited by this paper
• A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

  1961cited by this paper

• A functional interaction between the CCR5 and CD34 molecules expressed in hematopoietic cells can support (or even promote) the development of cancer

  2019cites this paper
• Analysis of the Spanish CCR5-∆32 inventory of cord blood units: lower cell counts in homozygous donors

  2018cites this paper
• Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.

  2012cites this paper
• Acute myocardial infarction and cardiogenic shock

  2012cites this paper
• Enhancement of Antitumor Radiation Efficacy and Consistent Induction of the Abscopal Effect in Mice by ECI301, an Active Variant of Macrophage Inflammatory Protein-1α

  2008cites this paper
• Estudi immunogenètic de les quimiocines CCL4 i CCL4L

  2008cites this paper
• IN VITRO AND IN VIVO CHEMOTACTIC EFFECT OF M I P-l a GENE TRANSFECTED TUMOR VACCINE ON IMMUNE EFFECTOR CELLS 1

  2007cites this paper
• EX VIVO-EXPANSION OF CORD BLOOD CELLS AND ITS CLINICAL APPLICATION

  2006cites this paper
• Macrophage Inflammatory Proteins

  2002cites this paper
• NOD/SCID repopulating cells but not LTC-IC are enriched in human CD34+ cells expressing the CCR1 chemokine receptor

  2001cites this paper
• Regulation of Hematopoiesis by Chemokine Family Members

  2001cites this paper
• RAPID COMMUNICATION BB-10010: An Active Variant of Human Macrophage Inflammatory Protein-la With Improved Pharmaceutical Properties

  2000cites this paper
• High-level secretion of biologically active recombinant human macrophage inflammatory protein-1alpha by the methylotrophic yeast Pichia pastoris.

  2000cites this paper
• Identification and Characterization of a Rat Macrophage Inflammatory Protein-1α Receptor

  2000cites this paper
• Influence of Cell Cycle and Oncogene Activity upon Topoisomerase IIα Expression and Drug Toxicity

  2000cites this paper
• Identification and characterization of a rat macrophage inflammatory protein-1alpha receptor.

  2000cites this paper
• Chemokines, chemokine receptors and hematopoiesis

  2000cites this paper
• Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2.

  1999cites this paper
• Effects of CC, CXC, C, and CX3C Chemokines on Proliferation of Myeloid Progenitor Cells, and Insights into SDF‐1‐Induced Chemotaxis of Progenitors a

  1999cites this paper
• Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants.

  1999cites this paper
• Distinct biological effects of macrophage inflammatory protein-1alpha and stroma-derived factor-1alpha on CD34+ hemopoietic cells.

  1999cites this paper
• Distinct Biological Effects of Macrophage Inflammatory Protein‐1α and Stroma‐Derived Factor‐1α on CD34+ Hemopoietic Cells

  1999cites this paper
• Macrophage Inflammatory Protein-1α and Stem Cell Inhibition

  1999cites this paper
• Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities.

  1999cites this paper
• Identification of Amino Acid Residues Critical for Aggregation of Human CC Chemokines Macrophage Inflammatory Protein (MIP)-1α, MIP-1β, and RANTES

  1999cites this paper
• Dominant Myelopoietic Effector Functions Mediated by Chemokine Receptor CCR1

  1999cites this paper
• Chemokines and Hematopoiesis

  1999cites this paper
• The growth inhibitory role and potential clinical value of macrophage inflammatory protein 1 alpha in myeloid leukaemias.

  1998cites this paper
• Abl protein kinase abrogates the response of multipotent haemopoietic cells to the growth inhibitor macrophage inflammatory protein-1 alpha

  1998cites this paper
• Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cells.

  1998cites this paper
• The molecular and cellular biology of the chemokines

  1998cites this paper
• Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancer.

  1998cites this paper
• Differential Response of CD34+ Cells Isolated from Cord Blood and Bone Marrow to MIP‐1α and the Expression of MIP‐1α Receptors on These Immature Cells

  1998cites this paper
• Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 alpha (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010.

  1998cites this paper
• 7 Growth inhibitors in haemopoiesis and leukaemogenesis

  1997cites this paper
• Haemopoietic stem cells: their heterogeneity and regulation

  1997cites this paper
• Growth inhibitors in haemopoiesis and leukaemogenesis.

  1997cites this paper
• Expression, purification, and characterization of Escherichia coli-derived recombinant human melanoma growth stimulating activity.

  1997cites this paper
• Macrophage Inflammatory Protein-1 Alpha: A Paradox?

  1997cites this paper
• In vitro andin vivo chemotactic effect of mip-lα gene transfected tumor vaccine on immune effector cells

  1997cites this paper
• Specificity and reciprocity in the interactions between TGF-beta and macrophage inflammatory protein-1 alpha.

  1996cites this paper
• BB-10010/MIP-1 alpha in vivo maintains haemopoietic recovery following repeated cycles of sublethal irradiation.

  1996cites this paper
• The Inhibitory Effect of Human Macrophage Inflammatory Protein‐1α (LD78) on Acute Myeloid Leukemia Cells in Vitro

  1996cites this paper
• The effect of the chemokine rhMIP‐1α, and a non‐aggregating variant BB‐10010, on blast cells from patients with acute myeloid leukaemia

  1996cites this paper
• Myelosuppressive Cytokines and Peptides

  1996cites this paper
• Feedback inhibitors in normal and tumor tissues.

  1996cites this paper
• Haemopoietic stem cell inhibition: potential for dose intensification.

  1995cites this paper
• Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice

  1995influential citation
• BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical properties.

  1995cites this paper
• MIP-1 alpha increases the self-renewal capacity of the hemopoietic spleen-colony-forming cells following hydroxyurea treatment in vivo.

  1995cites this paper
• Macrophage inflammatory protein-1 alpha mediated growth inhibition in a haemopoietic stem cell line is associated with inositol 1,4,5 triphosphate generation.

  1995cites this paper
• Aggregation of the chemokine MIP-1 alpha is a dynamic and reversible phenomenon. Biochemical and biological analyses.

  1994cites this paper
• MIP-1 alpha is a regulator of mitotic and meiotic DNA synthesis during spermatogenesis.

  1994cites this paper
• Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1 alpha.

  1994cites this paper
• MIP-1α is a regulator of mitotic and meiotic DNA synthesis during spermatogenesis

  1994cites this paper
• Polymerization of murine macrophage inflammatory protein 1 alpha inactivates its myelosuppressive effects in vitro: the active form is a monomer.

  1993cites this paper
• Characterization of a receptor for macrophage inflammatory protein 1 alpha and related proteins on human and murine cells.

  1993cites this paper
• Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.

  1993cites this paper
• Transforming growth factor beta: is it a downregulator of stem cell inhibition by macrophage inflammatory protein 1 alpha?

  1993cites this paper
• Ways of minimising hematopoietic damage induced by radiation and cytostatic drugs--the possible role of inhibitors.

  1993cites this paper
• Characterization of the quaternary structure and conformational properties of the human stem cell inhibitor protein LD78 in solution.

  1993cites this paper
• Does stem cell exhaustion result from combining hematopoietic growth factors with chemotherapy? If so, how do we prevent it?

  1992cites this paper
• Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo.

  1992cites this paper